What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A new private space station race is heating up, and Vast is stepping in with a bold plan. This could shift how invest...
A blockbuster deal reshapes the media landscape and leaves Netflix with a substantial windfall. This article breaks d...
In March 2026, a new market roundup highlights the best direct access brokers for active traders, underscoring speed,...
Nvidia has dazzled investors with AI-driven growth, but a hidden threat could derail the rally. This article identifi...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Adobe posted solid quarterly results but faces mounting downgrades as analysts question AI monetization, pricing powe...
Tesla’s ambitious software push could reshape profits, but regulatory headwinds loom. This guide helps news tesla sha...
SBI Holdings and Rakuten are teaming up to build an in-house crypto investment trust as Japan updates its crypto rule...
SoFi has surprised some investors by turning a key profitability metric into a clear strength. This article breaks do...
A new Fed chair could reshape policy and markets. This guide explains chair kevin warsh plans, the potential economic...
When stars hit the red carpet, it isn’t just fashion and fame at stake. This article breaks down the money moves behi...